Início › Câncer Metastático › Novo México › Albuquerque
Ensaios clínicos de Câncer Metastático em Albuquerque, NM
12 estudos para Câncer Metastático estão buscando participantes em locais em Albuquerque e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- University of New Mexico Cancer Center, Albuquerque
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecrutandoFase 2/3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecrutandoFase 3
- Research Site, Albuquerque
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RecrutandoEstudo observacional
- New Mexico Oncology Hematology Consultants, Albuquerque
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Optimum Clinical Research Group, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecrutandoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecrutandoFase 3
- Research Site, Albuquerque
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RecrutandoFase 1
- New Mexico Oncology Hematology Consultants Ltd, Albuquerque
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecrutandoFase 1/2
- Presbyterian Kaseman Hospital (site 208), Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Albuquerque
Ensaios de Câncer Metastático em outras cidades
- Houston, TX104 estudos
- New York City, NY93 estudos
- Nashville, TN70 estudos
- Boston, MA63 estudos
- Los Angeles, CA57 estudos
- St. Louis, MO54 estudos
- Arlington, VA53 estudos
- Philadelphia, PA46 estudos
- Chicago, IL45 estudos
- San Antonio, TX44 estudos
- Washington, DC43 estudos
- Dallas, TX42 estudos
Outros estudos em Albuquerque
- Câncer de Pulmão de Não Pequenas Células18 estudos
- Câncer de Mama17 estudos
- Câncer de Ovário15 estudos
- Câncer (todos os tipos)14 estudos
- Câncer de Pulmão14 estudos
- Câncer Endometrial12 estudos
- Diabetes tipo 211 estudos
- Doença Cardiovascular10 estudos
- Melanoma9 estudos
- Leucemia Mieloide Aguda9 estudos
- Câncer de Próstata9 estudos
- Doença Renal Crônica8 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.